Status:
COMPLETED
Metabolic Syndrome Diagnosis and Education Trial
Lead Sponsor:
Mayo Clinic
Conditions:
Metabolic Cardiovascular Syndrome
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study is being done to gain knowledge on how effective different approaches of providing a diagnosis and varying educational tools that include DVDs and multimedia or printed instruction sheets o...
Eligibility Criteria
Inclusion
- Any 3 of the following 5:
- History of hypertension or either systolic blood pressure \>125 or diastolic blood pressure \>85 mmHg or documented history and receiving treatment for it
- Abdominal circumference ≥40 inches in men or ≥35 inches in women
- Fasting triglycerides ≥ 150mg/dL or receiving treatment for it
- Fasting blood glucose ≥ 100mg/dL but \<126mg/dL
- HDL cholesterol \<40mg/dL in men or \<50mg/dL in women or receiving treatment for it
Exclusion
- Documented diagnosis of metabolic syndrome in the clinical record, if previously seen at Mayo.
- History of coronary artery disease
- Diabetes mellitus, or using an oral hypoglycemic pill for glucose intolerance
- Congestive heart failure
- Familial hypercholesterolemia including familial hypertriglyceridemia,
- Fasting LDL-cholesterol \>160 mg/dL
- Fasting triglycerides \> 390 mg/dL
- Have systolic blood pressure \>160 and diastolic blood pressure \>100mg/dL
- History of hypertension with changes in their blood pressure medicines within the last 60 days before enrollment.
- History of dyslipidemia and changes on their lipid lowering agents such as statins, ezetimibe, fibrates or niacin within the last 60 days before enrollment.
- Secondary causes of obesity such as hypothyroidism, Cushing syndrome, or eating disorders
- Pregnant women or women planning to get pregnant during the duration of the study
- Advanced liver disease
- Renal insufficiency
- Having any other major chronic medical condition
- Unable to do their basic chores at home due to musculoskeletal limitations or other factors affecting their functional status.
- Physical activity of more than 60 minutes per week of moderate to intense exercise
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00943254
Start Date
October 1 2007
End Date
August 1 2010
Last Update
October 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905